Contact Us
Partner Login
FDA Regulatory Consulting Services | MiCOM Labs
A2LA Accredited · ISO/IEC 17025 · Certificate #2381.01

FDA Regulatory Consulting Services

Medical device manufacturers face complex FDA regulatory requirements before reaching the U.S. market. MiCOM Labs provides expert guidance on device classification, submission strategy, and compliance pathways to help you navigate 510(k), De Novo, and PMA processes efficiently.

Schedule a Free Regulatory Consultation

FDA Submission Pathways for Medical Devices

Navigating FDA submission pathways is essential for bringing a medical device to market. The appropriate route, 510(k), De Novo, or PMA, depends on a device’s risk, novelty, and intended use, each with distinct requirements, timelines, and costs.

510(k) Premarket Notification

The 510(k) pathway demonstrates substantial equivalence to an existing legally marketed device. This route applies to most Class Ii devices and some Class I products that are not exempt from premarket notification.

  • Key Requirements:
  • Predicate device identification
  • Comparison of technological characteristics
  • Performance data demonstrating equivalence

Review Timeline: 90 days from receipt to decision. The FDA reported an average review time of 163 days in 2023.

User Fee (FY 2025): $24,335 standard fee ($6,084 for small businesses).

Approximately 70% of medical devices entering the U.S. market follow the 510(k) pathway.

De Novo Classification Request

The De Novo pathway provides market authorization for novel medical devices with no predicate that present low to moderate risk. Devices classified under De Novo establish new device categories that future manufacturers can reference in 510(k) submissions.

  • Key Requirements:
  • Demonstration that general controls or special controls provide reasonable assurance of safety
  • Clinical data, when applicable
  • Non-clinical performance testing
  • Benefit-risk analysis

Review Timeline: 150 review days, excluding hold time for additional information.

User Fee (FY 2025): $162,235 standard fee ($40,559 for small businesses).

The FDA cleared 17 De Novo requests in 2023, reflecting the pathway's growing importance for innovative medical technologies.

Premarket Approval Application

The PMA pathway represents the most rigorous FDA review process. It applies to Class III devices that support human life, prevent health impairment, or present a potential risk of illness or injury.

  • Key Requirements:
  • Clinical data demonstrating safety and effectiveness
  • Manufacturing and quality system documentation
  • Facility inspection before approval

Review Timeline: 180 review days excluding hold time. The total process typically requires 12 to 18 months.

User Fee (FY 2025): $540,783 standard fee ($135,196 for small businesses).

Understanding FDA Device Classification — Risk-Based Categories

The FDA classifies medical devices into three risk-based categories that determine the regulatory pathway required for market clearance.

Classification Risk Level Regulatory Controls
Class I Low risk General controls
Class II Moderate risk General and special controls
Class III High risk Premarket approval

Class I devices include low-risk products such as tongue depressors. Class II devices encompass moderate-risk equipment, including powered wheelchairs. Class III devices are high-risk technologies, such as implantable pacemakers, that support human life.

Device classification directly impacts the submission pathway, review timeline, and data requirements for FDA market authorization.

Request Your Free De Novo Assessment →

Regulatory Pathway Comparison

FDA submission routes vary significantly depending on device risk and novelty. Choosing the correct pathway determines the target review days, user fees, and required testing data.

Pathway Target Review Days Standard User Fee Application
510(k) 90 days $24,335 Devices with predicates
De Novo 150 review days $162,235 Novel low-moderate risk devices
PMA 180 days $540,783 High-risk Class III devices

Source: FDA FY 2025 Medical Device User Fees; Educo Life Sciences

Get Your Testing Scope Proposal →

Testing Requirements for FDA Submissions

FDA submissions require test data from accredited laboratories holding ISO/IEC 17025 certification. Test results must meet documentation and traceability standards recognized globally by regulatory authorities.

Electrical Safety Testing

Medical device manufacturers targeting international markets require testing and certification across multiple jurisdictions. MiCOM Labs holds direct certification authority in five major markets through bilateral mutual recognition agreements.

Electromagnetic Compatibility Testing

IEC 60601-1-2 mandates EMC testing for medical electrical equipment. Testing validates that devices operate reliably in clinical environments without causing harmful interference.

Wireless Device Testing

Connected medical devices require RF compliance testing for FCC Part 15, Part 18, or Part 27, depending on wireless technology. Testing demonstrates that devices meet emission limits and operate without causing harmful interference.

Contact Us About Your Testing Requirements →

MiCOM Labs Regulatory Support Services

MiCOM Labs provides comprehensive testing and compliance support for medical device manufacturers navigating FDA requirements.

A2LA-Accredited Testing Laboratory

Accredited under ISO/IEC 17025, ensuring test results meet FDA and global regulatory standards.

Key Benefit: Recognized, compliant test data for submissions

Real-Time Testing Visibility

MiTest® platform provides live project updates and access to provisional results.

Key Benefit: Improved transparency and faster decision-making

Certification Management Platform

MiCMS® platform enables workflow tracking, document management, and automated alerts.

Key Benefit: Streamlined certification and compliance process

Pre-Submission Strategies to Reduce Review Time

Engaging with the FDA before formal submission can prevent costly redesigns and regulatory setbacks.

513(g) Request for Classification

Timeline: 60 days | Fee (Standard): $7,301

Provides a formal FDA determination of device classification to ensure clarity early in development.

Pre-Submission (Q-Sub) Consultation

Timeline: Varies (pre-submission phase) | Fee (Standard): No standard fee

Allows discussion with the FDA on testing, documentation, and requirements to identify gaps early.

Contact Us About Your Testing Requirements
Direct Certification Markets

Global Market Access Beyond FDA

Medical device manufacturers targeting international markets require testing and certification across multiple jurisdictions. MiCOM Labs holds direct certification authority in five major markets through bilateral mutual recognition agreements.

Market Regulatory Body MiCOM Labs Status
🇺🇸 United States
FCC Telecommunication Certification Body (TCB)
🇨🇦 Canada
ISED Foreign Certification Body (FCB)
🇪🇺 European Union
CE Notified Body under US-EU MRA
🇬🇧 United Kingdom
UKCA Approved Body under US-UK MRA
🇯🇵 Japan
MIC Registered Certification Body (RCB)
🇺🇸 United States
FCC Telecommunication Certification Body (TCB)
🇨🇦 Canada
ISED Foreign Certification Body (FCB)
🇪🇺 European Union
CE Notified Body under US-EU MRA
🇬🇧 United Kingdom
UKCA Approved Body under US-UK MRA
🇯🇵 Japan
MIC Registered Certification Body (RCB)

Source: MiCOM Labs Certification Authority Documentation

MiCOM Labs also conducts testing for nine additional economies under the APEC TEL MRA Phase I. These include Australia, Taiwan, Hong Kong, Malaysia, New Zealand, South Korea, Singapore, Vietnam, and Mexico.

Regulatory Compliance Process

MiCOM Labs follows a structured process for medical device compliance testing and regulatory support.

1–2 days

Initial Assessment

Equipment specifications reviewed, user manuals evaluated, applicable standards identified

2–3 days

Test Planning

Detailed test protocol developed, sample requirements documented, timeline estimated

1–2 weeks

Physical Testing

Electrical safety verification, EMC evaluation, RF compliance testing, and environmental validation

2–3 days

Report Generation

ISO/IEC 17025-compliant test reports issued, compliance determinations documented, and graphical results provided

1–2 weeks

Certification Support

Applications submitted to regulatory authorities, status tracking via MiCMS®, and declarations of conformity issued

Initial Assessment

1–2 days

Equipment specifications reviewed, user manuals evaluated, applicable standards identified

Test Planning

2–3 days

Detailed test protocol developed, sample requirements documented, timeline estimated

Physical Testing

1–2 weeks

Electrical safety verification, EMC evaluation, RF compliance testing, and environmental validation

Report Generation

2–3 days

ISO/IEC 17025-compliant test reports issued, compliance determinations documented, and graphical results provided

Certification Support

1–2 weeks

Applications submitted to regulatory authorities, status tracking via MiCMS®, and declarations of conformity issued

Source: MiCOM Labs testing process documentation
Request Your Detailed Timeline Estimate

Industries Served

MiCOM Labs supports medical device manufacturers across multiple industry segments requiring FDA regulatory compliance.

Medical and Clinical Laboratories

In vitro diagnostic systems, clinical chemistry analyzers, and hematology instruments require comprehensive testing before regulatory approval. Laboratory automation systems and sample-handling equipment must meet applicable safety and EMC standards.

Connected Health Devices

Wireless patient monitors, remote diagnostic equipment, and telehealth systems need RF compliance certification. Testing covers wireless performance, electromagnetic compatibility, and electrical safety requirements.

Diagnostic Equipment

Medical imaging accessories, laboratory test equipment, and diagnostic analyzers require testing to validate safety compliance and electromagnetic compatibility in healthcare environments.

Frequently Asked Questions

Devices qualify for De Novo when no legally marketed predicate exists, and the device presents low to moderate risk. The manufacturer must demonstrate that general controls or general controls with special controls provide reasonable assurance of safety and effectiveness.

Yes. Since the FDA final rule in October 2021, manufacturers can submit De Novo requests directly when they determine that no predicate device exists. This eliminates the need to obtain a not substantially equivalent determination first.

The FDA's review goal targets 150 FDA review days, excluding hold periods. Total time from testing initiation through final decision typically ranges from six to nine months, depending on device complexity and the completeness of initial documentation.

The device remains in Class III. Manufacturers must either submit a Premarket Approval (PMA) application or collect additional data to address the identified deficiencies and submit a new De Novo request.

MiCOM Labs provides comprehensive testing services for bench performance, electrical safety, EMC, and RF compliance. For clinical studies, we coordinate with qualified clinical research organizations while managing the overall compliance timeline.

Navigate FDA Requirements with Expert Support

Medical device manufacturers benefit from early engagement with accredited testing laboratories that understand FDA submission requirements. Proper classification, appropriate pathway selection, and comprehensive testing data reduce review delays and increase approval success rates.

MiCOM Labs delivers A2LA-accredited testing services for medical device manufacturers navigating FDA compliance requirements. Our automated testing platforms and direct certification authority in major markets reduce time-to-market while ensuring regulatory acceptance.

Contact MiCOM Labs to discuss your device specifications, target markets, and testing requirements. Receive a detailed proposal outlining applicable standards, testing scope, and regulatory timelines.

Request Your Regulatory Assessment Today